Found: 36
Select item for more details and to access through your institution.
Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00815
- By:
- Publication type:
- Article
<sup>18</sup>F‐FDG PET/CT for response evaluation of regional lymph nodes in 97 head and neck squamous cell carcinoma patients: Differences in the predictive value of residual disease after radiotherapy and chemoradiotherapy.
- Published in:
- Clinical Otolaryngology, 2020, v. 45, n. 5, p. 805, doi. 10.1111/coa.13566
- By:
- Publication type:
- Article
Considerable interlaboratory variation in PD‐L1 positivity for head and neck squamous cell carcinoma in the Netherlands— A nationwide evaluation study.
- Published in:
- Histopathology, 2024, v. 85, n. 1, p. 133, doi. 10.1111/his.15184
- By:
- Publication type:
- Article
Lesion detection by [<sup>89</sup>Zr]Zr-DFO-girentuximab and [<sup>18</sup>F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1931, doi. 10.1007/s00259-019-04358-9
- By:
- Publication type:
- Article
Feedback preferences of patients, professionals and health insurers in integrated head and neck cancer care.
- Published in:
- Health Expectations, 2017, v. 20, n. 6, p. 1275, doi. 10.1111/hex.12567
- By:
- Publication type:
- Article
Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1374, doi. 10.3390/cancers15051374
- By:
- Publication type:
- Article
A patient with metastatic melanoma presenting with gastrointestinal perforation after dacarbazine infusion: a case report.
- Published in:
- 2010
- By:
- Publication type:
- journal article
From presentation to paper: Gender disparities in oncological research.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 11, p. 3011, doi. 10.1002/ijc.32660
- By:
- Publication type:
- Article
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 4, p. 758, doi. 10.1002/ijc.31353
- By:
- Publication type:
- Article
Development and Validation of a Prediction Model for Tube Feeding Dependence after Curative (Chemo-) Radiation in Head and Neck Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094879
- By:
- Publication type:
- Article
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
- Published in:
- Head & Neck, 2020, v. 42, n. 11, p. 3141, doi. 10.1002/hed.26363
- By:
- Publication type:
- Article
Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.
- Published in:
- Head & Neck, 2018, v. 40, n. 3, p. 605, doi. 10.1002/hed.25035
- By:
- Publication type:
- Article
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults.
- Published in:
- Head & Neck, 2017, v. 39, n. 1, p. 140, doi. 10.1002/hed.24556
- By:
- Publication type:
- Article
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 3, p. 1539, doi. 10.1007/s12253-019-00734-w
- By:
- Publication type:
- Article
Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
- Published in:
- Journal of Laryngology & Otology, 2024, v. 138, n. 6, p. 672, doi. 10.1017/S0022215124000112
- By:
- Publication type:
- Article
Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
- Published in:
- Oncologist, 2016, v. 21, n. 8, p. 995, doi. 10.1634/theoncologist.2015-0451
- By:
- Publication type:
- Article
Use of selective serotonin reuptake inhibitors is associated with very low plasma-free serotonin concentrations in humans.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic area.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 2, p. 1, doi. 10.1007/s00432-023-05547-8
- By:
- Publication type:
- Article
mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1447555
- By:
- Publication type:
- Article
Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with 'untargeted' side effects.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1944, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with 18F-FDG-PET Compared to 99mTechnetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
Assessment of Bone Lesions with <sup>18</sup>F-FDG-PET Compared to <sup>99m</sup>Technetium Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244640
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 905, doi. 10.2967/jnumed.116.183475
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
- By:
- Publication type:
- Article
Everolimus Reduces <sup>89</sup>Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 7, p. 1087, doi. 10.2967/jnumed.113.129056
- By:
- Publication type:
- Article
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11094-9
- By:
- Publication type:
- Article
Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00761
- By:
- Publication type:
- Article